Analysts: What to Expect in Express Scripts’s Results and 3 More Research Notes to Check Out

Express Scripts (NASDAQ:ESRX): SunTrust expects Express Scripts to report $1.10 for earnings per share and $25.5 billion for revenue with Ebitda of $1.734 billion when the company reports its quarterly earnings on Monday night. The analyst expects positive commentary regarding the selling season and continued updates on FCF deployment. The shares are Buy rated with a $68 price target.

esrx

American Railcar (NASDAQ:ARII): Following the company’s report of higher-than-expected second-quarter EPS, Longbow thinks that tank car demand is likely to remain strong in the intermediate term. The firm believes investors may be overlooking a couple of the company’s positive catalysts and reiterates a Buy rating on the shares.

arii

Mylan Technologies (NASDAQ:MYL): Susquehanna raised its price target on Mylan to $39 from $33 ahead of its investors day, as the firm expects the company to reinforce its organic growth outlook and expects solid second-quarter results. The firm rates the shares at Positive.

myl

Tesaro (NASDAQ:TSRO): Morgan Stanley said Tesaro’s IV Rolapitant dose-escalation trial will begin this quarter, and that timelines for a mid-2015 launch of the oral version look achievable with Ph 3 data by year’s end. The firm reiterates its Overweight rating and raised its price target on the shares to $45 from $29.

tsro

Don’t Miss: FDA Is Restricting This Johnson & Johnson Drug.

More Articles About:   ,  

More from The Cheat Sheet